Medications Development Program Projects for Substance-Related Disorders (P01)

The summary for the Medications Development Program Projects for Substance-Related Disorders (P01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Medications Development Program Projects for Substance-Related Disorders (P01): With this Funding Opportunity Announcement (FOA), the National Institute on Drug Abuse (NIDA) solicits investigator-initiated program project (P01) grant applications that advance the discovery/development of new or existing therapeutics for the treatment of substance-related disorders (SRDs). Research projects in a program project grant must be closely related to a central theme that can be conducted effectively and efficiently through a coordinated collaborative approach using common resources, facilities, and instruments. Each research project within the P01 award must be supportable on its own merit. The scientific merit of each research project is assessed independently as well as within the context of the whole program. This initiative is designed to support an array of translational research programs, each comprised of at least three interrelated preclinical and/or clinical projects. As part of the program project, applicants are encouraged to develop synergistic collaborations with industry that enhance and strengthen the overall developmental potential of the proposed work. While the inclusion of an Administrative Core or other core is optional, it is expected that the PD/PI (or a multi-PI-coordinating group) will be responsible for the overall coordination of the program project and communication between components. Program projects can focus on the development of any sort of novel treatment strategies for cocaine, methamphetamine, cannabis, nicotine or opioid SRDs.
Federal Grant Title: Medications Development Program Projects for Substance-Related Disorders (P01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-12-005
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Jul 29, 2011
Original Application Deadline: Jul 29, 2011
Posted Date: Mar 29, 2011
Creation Date: Mar 29, 2011
Archive Date: Aug 29, 2011
Total Program Funding: $3,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are not allowed.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional)
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Phar...
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Phar...
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Op...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com